Actinium Pharmaceuticals, Inc.
Biotechnology ResearchView the employees at
Actinium Pharmaceuticals, Inc.-
Amanda Chin, PhD Research Scientist
-
New York, New York, United States
-
Top 5%
Adrian Hackett Associate Director Preclinical Toxicology at Actinium Pharmaceuticals-
New York City Metropolitan Area
-
Top 10%
Weiqing Wang Corporate finance and investor relations associate at Actinium Pharmaceuticals, Inc.-
New York, New York, United States
-
Top 10%
Nima Moayer VP | Executive Director | Senior Director | Pharmaceutical Marketing | Commercial Leadership | Brand Strategy | Product Launch | Rare Diseases | Omnichannel Marketing | Market Access | Business Analytics & Insights-
New York City Metropolitan Area
-
Rising Star
Garth Parham, Ph.D. Executive Leader Leveraging Scientific,Technical & Business Expertise ׀ Steers Early Stage Drug Discovery Mission-Critical Teams & Projects From Concept Through Preclinical Development ׀ Delivering Investor ROI-
Indianapolis, Indiana, United States
-
Top 5%
Overview
Actinium Pharmaceuticals (NYSE: ATNM) is focused on developing innovative targeted radioimmunotherapies for the treatment of advanced cancers. Currently Investigating therapies in #AML and #BMT
-